BTTX

0.00010.00%
MA

Mark A. Berman

Chief Medical Officer

Dr. Mark A. Berman, MD, has been the Chief Medical Officer at Better Therapeutics, Inc. since October 2021. Dr. Berman oversees all clinical development and delivery and leads regulatory, research and publication efforts. He is an internal medicine physician and social entrepreneur whose work focuses on cardiometabolic health, plant-based diets and digital therapeutics. He served as Director of Medical Programs at Keas Inc. Dr. Berman specializes in obesity prevention, lifestyle modification and weight management, having served as an obesity medicine consultant for Harvard Health Publications. Concurrently, he has been the special assistant to the Chief Executive Officer and President of the Robert Wood Johnson Foundation for Childhood Obesity Prevention. He completed a combined residency in internal medicine and primary care at Brigham & Women's Hospital, Harvard Medical School, where he practiced both primary care and weight management at Harvard Vanguard Medical Associates in Boston. He received his MD from Yale University School of Medicine and studied physical therapy at McGill University. He was a Doris Duke Clinical Research Fellow at UCSF. He is also a fellow and past director of the American College of Lifestyle Medicine.

Positions